Retrieve Medical Holdings, Inc. 10-Q

Item 5. Other Information None. 16 Item 6. Exhibits Exhibit Number Description (2) Plan of acquisition, reorganization, arrangement, liquidation or succession 2.1 Articles of Merger (incorporated by reference to our Registration Statement on Form 8-K filed on September 5, 2013) 2.2 Agreement and Plan of Merger (incorporated by reference to our Registration Statement on Form 8-K filed on September 5, 2013) 2.1 Articles of Merger (incorporated by reference to our Registration Statement on Form 8-K filed on March 20, 2014) 2.2 Agreement and Plan of Merger (incorporated by reference to our Registration Statement on Form 8-K filed on March 20, 2014) 2.1 Articles of Merger (incorporated by reference to our Registration Statement on Form 8-K filed on December 30, 2014) 2.2 Agreement and Plan of Merger (incorporated by reference to our Registration Statement on Form 8-K filed on December 30, 2014) (3) (i) Articles of Incorporation; and (ii) Bylaws 3.1 Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1 filed on December 29, 2008) 3.1.2 Certificate of Amendment to Articles of Incorporation (incorporated by reference to our Registration Statement on Form 10-K filed on December 26, 2012) 3.1.3 Certificate of Change (incorporated by reference to our Registration Statement on Form 10-K filed on December 26, 2012) 3.2 Bylaws (incorporated by reference to our Registration Statement on Form S-1 filed on December 29, 2008) (4) Instruments Defining the Rights of Security Holders, Including Indentures 4.1 Specimen Common Stock Certificate (incorporated by reference to our Registration Statement on Form S-1 filed on December 29, 2008) 4.1 Form of Registrant’s 10% Senior Convertible Promissory Note (incorporated by reference to our Registration Statement on Form 8-K filed on October 17, 2013) (10) Material Contracts 10.1 Convertible Promissory Note dated March 21, 2017 with Trius Holdings Limited (incorporated by reference to our Registrant’s Quarterly Report on Form 10-Q filed on March 31, 2016.) 10.2 Convertible Promissory Note dated March 30, 2017 with SukhAthwal (incorporated by reference to our Registrant’s Quarterly Report on Form 10-Q filed on March 31, 2016.) (31) Rule 13a-14(a)/15d-14(a) Certification 31.1* Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer 31.2* Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer (32) Section 1350 Certification 32.1* Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer 32.2* Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer (101)* Interactive Data Files 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document * Filed herewith. ** Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of any registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections. 17 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PEAK PHARMACEUTICALS, INC. By: /s/ Neil Reithinger______________ Neil Reithinger Chief Executive Officer and Chief Financial Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) Date: February 15, 2018 18